Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             204 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case-control study of lung cancer with special reference to the effect of air pollution in Poland 1991
7 3 p. 181-
1 p.
artikel
2 A case-control study of serum vitamins A, E, and C in lung cancer patients 1991
7 3 p. 179-
1 p.
artikel
3 A case of asynchronous triple primary malignant tumors of bladder, stomach and lung 1991
7 3 p. 195-
1 p.
artikel
4 A case report of minimally sized small cell carcinoma in the bronchus with extramural and venous extension 1991
7 3 p. 198-
1 p.
artikel
5 Acute nonlymphocytic leukemia following chemotherapy with cisplatin and etoposide for non-small-cell carcinoma of the lung: case report 1991
7 3 p. 203-
1 p.
artikel
6 Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer: A phase I/II study 1991
7 3 p. 200-
1 p.
artikel
7 Advances in nursing management of patients with lung cancer 1991
7 3 p. 212-
1 p.
artikel
8 Aerosol application of interferon-alpha in the treatment of bronchioloalveolar carcinoma 1991
7 3 p. 207-
1 p.
artikel
9 A human monocyte growth factor produced by lung cancer cells 1991
7 3 p. 187-
1 p.
artikel
10 Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer 1991
7 3 p. 184-
1 p.
artikel
11 Anaesthesia for resection of tumours in the trachea and central bronchi using the Nd-YAG-laser technique 1991
7 3 p. 211-
1 p.
artikel
12 Analysis of the decreased NK (natural killer) activity in lung cancer patients, using whole blood versus separated mononuclear cells 1991
7 3 p. 194-
1 p.
artikel
13 Analytical and quantitative cytology and histology: Small-cell-type poorly differentiated squamous cell carcinoma of the lung: Cytologic, immunohistochemical and nuclear DNA content analysis 1991
7 3 p. 186-
1 p.
artikel
14 A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro 1991
7 3 p. 187-
1 p.
artikel
15 An overview of prognostic factors in small cell lung cancer. A report from the Subcommitte for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research 1991
7 3 p. 191-192
2 p.
artikel
16 Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4′-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage 1991
7 3 p. 202-203
2 p.
artikel
17 Anti-neuronal antibodies in paraneoplastic neurological disorders with small-cell lung carcinoma 1991
7 3 p. 195-
1 p.
artikel
18 Antitumor activity of L6-ricin immunotoxin against the H2981-T3 lung adenocarcinoma cell line in vitro and in vivo 1991
7 3 p. 185-
1 p.
artikel
19 A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: A preliminary report 1991
7 3 p. 201-
1 p.
artikel
20 A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicity 1991
7 3 p. 205-
1 p.
artikel
21 A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association Study 1991
7 3 p. 199-200
2 p.
artikel
22 A pilot study with an ifosfamide, carboplatin and etoposide regimen (ICE) in patients with advanced non-small-cell lung cancer 1991
7 3 p. 207-
1 p.
artikel
23 Application of squamous cell carcinoma associated antigen monoclonal radioimmunoassay in the diagnosis of bronchogenic carcinoma Lau-Wong, Mamie M.
1991
7 3 p. 151-155
5 p.
artikel
24 A randomised trial of cisplatin and vindesine versus supportive care only in advance non-small cell lung cancer 1991
7 3 p. 200-
1 p.
artikel
25 A randomized comparison of cisplatin-vindesine and cisplatin-etoposide for the treatment of previously untreated, advanced non-small cell lung cancer 1991
7 3 p. 204-
1 p.
artikel
26 A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861 1991
7 3 p. 207-
1 p.
artikel
27 A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer 1991
7 3 p. 203-
1 p.
artikel
28 A resected case of primary lung cancer with dermatomyositis 1991
7 3 p. 197-
1 p.
artikel
29 A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance 1991
7 3 p. 204-
1 p.
artikel
30 Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells 1991
7 3 p. 183-
1 p.
artikel
31 Biology of small cell lung cancer: An overview 1991
7 3 p. 211-
1 p.
artikel
32 Bronchogenic carcinoma presenting as neuromusculoskeletal pain 1991
7 3 p. 194-
1 p.
artikel
33 Bronchogenic carcinoma treated by concomitant resection of lung and chest wall 1991
7 3 p. 198-199
2 p.
artikel
34 Bronchoplastic surgery in bronchial carcinoma 1991
7 3 p. 198-
1 p.
artikel
35 Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer 1991
7 3 p. 200-
1 p.
artikel
36 Changes in regional ventilation and perfusion of the lung after endoscopic laser treatment 1991
7 3 p. 210-
1 p.
artikel
37 Characterization of an etoposide-resistant human small-cell lung cancer cell line 1991
7 3 p. 206-
1 p.
artikel
38 Chemo-radioresistance of small cell lung cancer cell lines derived from untreated primary tumors obtained by diagnostic bronchofiberscopy 1991
7 3 p. 191-
1 p.
artikel
39 Chemosensitivity test for lung cancer 1991
7 3 p. 206-
1 p.
artikel
40 Chemosensitivity testing of human lung cancer tissues using the succinate dehydrogenase inhibition test 1991
7 3 p. 204-
1 p.
artikel
41 Chemotherapy for metastatic non-small-cell lung cancer. A case report 1991
7 3 p. 202-
1 p.
artikel
42 Chemotherapy for unresectable non-small cell lung cancer 1991
7 3 p. 205-
1 p.
artikel
43 Chemotherapy in adenocarcinoma of the lung 1991
7 3 p. 204-
1 p.
artikel
44 Cigarette smoking as a cause of lung cancer and Coronary heart disease. A study of smoking-discordant twin pairs 1991
7 3 p. 179-
1 p.
artikel
45 Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm 1991
7 3 p. 202-
1 p.
artikel
46 Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: A combination phase II study 1991
7 3 p. 206-207
2 p.
artikel
47 Classifying clinical severity to help solve problems of stage migration in nonconcurrent comparisons of lung cancer therapy 1991
7 3 p. 194-
1 p.
artikel
48 Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis 1991
7 3 p. 195-196
2 p.
artikel
49 Cloned low metastatic variants from human lung carcinoma metastases 1991
7 3 p. 187-
1 p.
artikel
50 Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center 1991
7 3 p. 201-
1 p.
artikel
51 Combination cyclophosphamide and etoposide in treatment of small cell lung cancer 1991
7 3 p. 200-201
2 p.
artikel
52 Comparison of fibre types and size disbributions in lung tissues of paraoccupational and occupational cases of malignant mesothelioma 1991
7 3 p. 182-
1 p.
artikel
53 Comparison of high molecular weight alkaline phosphatase and glycylproline dipeptidylaminopeptidase for the detection of hepatic metastasis by liver function tests in lung cancer patients 1991
7 3 p. 193-
1 p.
artikel
54 Could cell kinetics be a predictor of prognosis in non-small cell lung cancer? Silvestrini, Rosella
1991
7 3 p. 165-170
6 p.
artikel
55 Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer 1991
7 3 p. 205-
1 p.
artikel
56 Current results of chemotherapy in non-small cell lung cancer 1991
7 3 p. 206-
1 p.
artikel
57 Cytogenetics of non-small cell lung cancer: Analysis of consistent non-random abnormalities 1991
7 3 p. 190-
1 p.
artikel
58 Decreased accumulation as a mechanism of resistance to cisdiamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: Relation to DNA damage and repair 1991
7 3 p. 183-184
2 p.
artikel
59 Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer - A quantitative Western blot analysis 1991
7 3 p. 192-193
2 p.
artikel
60 Detection of tumor necrosis factor/cachectin in pleural effusion of patients with lung cancer 1991
7 3 p. 193-194
2 p.
artikel
61 Determinants of drug response in a cisplatin-resistant human lung cancer cell line 1991
7 3 p. 203-
1 p.
artikel
62 Determinants of improved outcome in small-cell lung cancer: An analysis of the 2,580-patient Southwest Oncology Group Data Base 1991
7 3 p. 196-
1 p.
artikel
63 Differences in mortality associated with lung surgery 1991
7 3 p. 197-198
2 p.
artikel
64 Differential utilization of the SV40 enhancer and early promoter in various human lung carcinoma cell lines 1991
7 3 p. 184-
1 p.
artikel
65 Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol ester 1991
7 3 p. 186-
1 p.
artikel
66 Diffuse uptake of osteotropic radionuclide in the breast secondary to superior vena caval obstruction 1991
7 3 p. 191-
1 p.
artikel
67 Distribution of skeletal metastases in prostatic and lung cancer. Mechanisms of skeletal metastases 1991
7 3 p. 194-
1 p.
artikel
68 DNA adducts in different tissues of smokers and non-smokers 1991
7 3 p. 180-
1 p.
artikel
69 Does asbestosis increase the risk of lung cancer? 1991
7 3 p. 182-183
2 p.
artikel
70 Effect of guanine and adenine nucleotides on bombesin-stimulated phospholipase C activity in membranes from Swiss 3T3 and small cell lung carcinoma cells 1991
7 3 p. 189-
1 p.
artikel
71 Effect of inhaled natural interferon-alpha on diffuse bronchioalveolar carcinoma 1991
7 3 p. 207-
1 p.
artikel
72 Effects of IL-1 and cortisol on β-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells 1991
7 3 p. 186-187
2 p.
artikel
73 Effects of tumor necrosis factor, alone or in combination with topoisomerase-II-targeted drugs, on human lung cancer cell lines 1991
7 3 p. 205-
1 p.
artikel
74 Endobronchial radiation therapy (EBRT) in the management of lung cancer 1991
7 3 p. 208-
1 p.
artikel
75 Endoscopic photodynamic therapy in lung cancer 1991
7 3 p. 211-
1 p.
artikel
76 Endothelial cells enhance spontaneous metastasis of human lung carcinoma cells in athymic mice 1991
7 3 p. 184-
1 p.
artikel
77 Enhanced killing of human small cell lung cancer by hyperthermia and Indium-111-bleomycin complex 1991
7 3 p. 184-
1 p.
artikel
78 Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human lung cancer cell lines 1991
7 3 p. 204-
1 p.
artikel
79 Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan 1991
7 3 p. 182-
1 p.
artikel
80 Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial 1991
7 3 p. 203-
1 p.
artikel
81 Evaluation of 5-carbamoylmethyluridine as an indicator of tumor burden in lung cancer patients 1991
7 3 p. 196-
1 p.
artikel
82 Evaluation of high-dose etoposide combined with cisplatin for treating relapsed small cell lung cancer 1991
7 3 p. 202-
1 p.
artikel
83 Evidence of mendelian inheritance in the pathogenesis of lung cancer 1991
7 3 p. 182-
1 p.
artikel
84 Exposition to hard metal's dusts and bronchogenic carcinoma 1991
7 3 p. 183-
1 p.
artikel
85 Expression in lung cancer of a transcribed sequence at the DNF15S2 locus at chromosome 3P21 1991
7 3 p. 180-
1 p.
artikel
86 Expression of CYP1A1 gene in patients with lung cancer: Evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas 1991
7 3 p. 187-
1 p.
artikel
87 Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small cell carcinoma. Results from a randomized phase II trial 1991
7 3 p. 209-
1 p.
artikel
88 Four cases of lung cancer associated with idiopathic interstitial pneumonia 1991
7 3 p. 196-
1 p.
artikel
89 Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung 1991
7 3 p. 189-
1 p.
artikel
90 Future directions in the treatment of non-small cell lung cancer 1991
7 3 p. 211-
1 p.
artikel
91 Humoral leukocyte adherence inhibition (H-LAI) test in screening of high risk group for lung cancer 1991
7 3 p. 194-
1 p.
artikel
92 ‘Idiopathic thrombocytopenic purpura-like syndrome’ treated with interferon in a patient with lung cancer 1991
7 3 p. 192-
1 p.
artikel
93 Ifosfamide with mesna uroprotection in the management of lung cancer 1991
7 3 p. 201-
1 p.
artikel
94 Implications of nuclear diameter in small cell lung carcinoma 1991
7 3 p. 190-
1 p.
artikel
95 Incidence of mesothelioma in Glasgow 1981–1984 1991
7 3 p. 181-
1 p.
artikel
96 Increase of epidermal growth factor receptor expression associated with a lack of antiproliferative effect of IFN-β in human lung cancer nodules in organotypic culture 1991
7 3 p. 189-
1 p.
artikel
97 Indoor radon and lung cancer in China 1991
7 3 p. 181-
1 p.
artikel
98 Induction chemo-radiotherapy and maintenance alternating chemotherapy for small cell lung cancer 1991
7 3 p. 210-
1 p.
artikel
99 Intermediate dose rate remote afterloading brachytherapy for intraluminal control of bronchogenic carcinoma 1991
7 3 p. 208-209
2 p.
artikel
100 Intrinsic and acquired multidrug resistance in human lung carcinomas grown in nude mice 1991
7 3 p. 180-
1 p.
artikel
101 Investigation of a lung cancer cluster in the melt shop of an Ontario steel producer 1991
7 3 p. 180-
1 p.
artikel
102 Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976–1983 1991
7 3 p. 179-180
2 p.
artikel
103 Isochromosome (8q) in four patients with adenocarcinoma of the lung 1991
7 3 p. 189-190
2 p.
artikel
104 Joining of the c-myc gene and a line 1 family member on chromosome 8 in a human primary giant cell carcinoma of the lung 1991
7 3 p. 185-
1 p.
artikel
105 K-Ras oncogene activation as a prognostic marker in adenocarcinoma of the lung 1991
7 3 p. 188-
1 p.
artikel
106 L-2,4 diaminobutyric acid as a new therapeutic principle in the management of human bronchial neoplasms 1991
7 3 p. 208-
1 p.
artikel
107 Limited operation for lung carcinoma to preserve lung function 1991
7 3 p. 199-
1 p.
artikel
108 Localization of cathepsin B in two human lung cancer cell lines 1991
7 3 p. 190-
1 p.
artikel
109 Longevity in small lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research 1991
7 3 p. 209-
1 p.
artikel
110 Long-term survival after chest-wall reconstruction with musculocutaneous flaps 1991
7 3 p. 199-
1 p.
artikel
111 Loss of heterozygosity for genes on 11p and the clinical course of patients with lung carcinoma 1991
7 3 p. 192-
1 p.
artikel
112 Lung cancer and exposure to diesel exhaust among bus garage workers 1991
7 3 p. 183-
1 p.
artikel
113 Lung cancer and exposure to tobacco smoke in the household 1991
7 3 p. 179-
1 p.
artikel
114 Lung cancer and the debrisoquine metabolic phenotype 1991
7 3 p. 182-
1 p.
artikel
115 Lung cancer chemoprevention: facts and hopes Pastorino, Ugo
1991
7 3 p. 133-150
18 p.
artikel
116 Lung cancer: Value of computed tomography in radiotherapy planning and evaluation of tumour remission 1991
7 3 p. 209-
1 p.
artikel
117 Man-made mineral fibers and lung cancer. Epidemiologic evidence regarding the causal hypothesis 1991
7 3 p. 179-
1 p.
artikel
118 Mechanisms for acquired cytotoxic drug resistance in human small cell lung cancer and the potential utilization of resistance modifiers-a review with focus on in vitro studies 1991
7 3 p. 184-
1 p.
artikel
119 Mediastinal lymph node dissection - Anatomical basis and surgical significance in bronchial carcinoma 1991
7 3 p. 196-
1 p.
artikel
120 Metabolic activation of 4-ipomeanol in human lung, primary pulmonary carcinomas, and established human pulmonary carcinoma cell lines 1991
7 3 p. 205-
1 p.
artikel
121 Mitomycin, ifosfamide, and mesna in the treatment of lung cancer 1991
7 3 p. 204-
1 p.
artikel
122 Morphologic and immunocytochemical studies of bronchioloalveolar carcinoma at Duke university medical Center, 1968–1986 1991
7 3 p. 196-197
2 p.
artikel
123 Mortality from lung cancer among workers employed in formaldehyde industries 1991
7 3 p. 181-182
2 p.
artikel
124 Mortality of workers in the British cotton industry in 1968–1984 1991
7 3 p. 180-
1 p.
artikel
125 Multidisciplinary management of non-small cell lung cancer in the community 1991
7 3 p. 209-210
2 p.
artikel
126 NCAM: A surface marker for human small cell lung cancer cells 1991
7 3 p. 186-
1 p.
artikel
127 Neurone specific enolase (NSE) in small cell lung cancer: A tumour marker of prognostic significance? 1991
7 3 p. 192-
1 p.
artikel
128 Neuron-specific enolase (NSE). Serum RIA dosage in patients with extra-pulmonary neuroendocrine tumours 1991
7 3 p. 191-
1 p.
artikel
129 New directions in non-small cell lung cancer 1991
7 3 p. 211-
1 p.
artikel
130 Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line 1991
7 3 p. 207-208
2 p.
artikel
131 Overview of ifosfamide in small cell and non-small cell lung cancer 1991
7 3 p. 202-
1 p.
artikel
132 Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinoma 1991
7 3 p. 206-
1 p.
artikel
133 Phase II study of carboplatin in patients with nonresected lung cancer 1991
7 3 p. 200-
1 p.
artikel
134 Phase II study of carboplatin in untreated, inoperable non-small-cell lung cancer 1991
7 3 p. 206-
1 p.
artikel
135 Phase II study of 4′-epi-doxorubicin in patients with untreated, extensive small cell lung cancer 1991
7 3 p. 200-
1 p.
artikel
136 Phase II study of high-dose epirubicin in untreated patients with small-cell lung cancer 1991
7 3 p. 206-
1 p.
artikel
137 Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer 1991
7 3 p. 202-
1 p.
artikel
138 Photodetection and photodynamic therapy of ‘early’ squamous cell carcinomas of the pharynx, oesophagus and tracheo-bronchial tree 1991
7 3 p. 210-211
2 p.
artikel
139 Photosensitizing dyes for the selection of nontumorigenic revertants from human lung cancer cell lines 1991
7 3 p. 189-
1 p.
artikel
140 Pleuroperitoneal shunt for recurrent malignant pleural effusions 1991
7 3 p. 198-
1 p.
artikel
141 Polycyclic aromatic hydrocarbon - DNA adducts in lung tissue from lung cancer patients 1991
7 3 p. 188-
1 p.
artikel
142 Postoperative lung metastasis from primary lung cancer 1991
7 3 p. 197-
1 p.
artikel
143 Postpneumonectomy empyema. The role of intrathoracic muscle transposition 1991
7 3 p. 198-
1 p.
artikel
144 Potentiation of cisplatin by alpha-Interferon in advanced in non-small cell lung cancer (NSCLC): A phase II study 1991
7 3 p. 208-
1 p.
artikel
145 Predictors of 5-year survival and curability in small cell lung cancer 1991
7 3 p. 194-
1 p.
artikel
146 Present status and problems of surgical treatment of non-small cell lung cancer 1991
7 3 p. 199-
1 p.
artikel
147 Primary bony chest wall tumours 1991
7 3 p. 194-195
2 p.
artikel
148 Primary liposarcoma of the lung in a young woman 1991
7 3 p. 192-
1 p.
artikel
149 Production of gastrin-releasing peptide-(18–27) and a stable fragment of its precursor in small cell lung carcinoma cells 1991
7 3 p. 185-186
2 p.
artikel
150 Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours 1991
7 3 p. 184-
1 p.
artikel
151 Production of pancreastatin-like immunoreactivity, a presumed processing product of chromogranin A, in small cell lung carcinoma 1991
7 3 p. 190-
1 p.
artikel
152 Production of tumor necrosis factor-α by alveolar macrophages of lung cancer patients 1991
7 3 p. 185-
1 p.
artikel
153 Prognosis at presentation of small cell carcinoma of the lung 1991
7 3 p. 195-
1 p.
artikel
154 Prognosis of lung cancer patients with intrapulmonary metastasis diagnosed at thoractomy 1991
7 3 p. 197-
1 p.
artikel
155 Prognostic factors in resected stages I and II adenocarcinoma of the lung. A multivariate regression analysis of 137 consecutive patients 1991
7 3 p. 193-
1 p.
artikel
156 Progress and obstacles in chemotherapy and combined modality treatment of small cell lung cancer 1991
7 3 p. 210-
1 p.
artikel
157 Quality of life assessment during chemotherapy for non-small cell lung cancer 1991
7 3 p. 207-
1 p.
artikel
158 Quality of life during chemotherapy for small cell lung cancer: Assessment and use of a daily diary card in a randomized trial 1991
7 3 p. 203-
1 p.
artikel
159 Radiation therapy for medically inoperable stage I and II non-small cell lung cancer 1991
7 3 p. 208-
1 p.
artikel
160 Radioisotopic pulmonary lobectomy: Feasibility study in dogs 1991
7 3 p. 198-
1 p.
artikel
161 Radon and lung cancer: The BEIR IV report 1991
7 3 p. 182-
1 p.
artikel
162 Rationale for the use of chemotherapy in non-small cell lung cancer 1991
7 3 p. 188-
1 p.
artikel
163 Relationship of CA 125 and CA 19.9 with lung carcinoma histological subtype: Preliminary study 1991
7 3 p. 191-
1 p.
artikel
164 Report on the 3rd IASLC Lung Tumour Biology Workshop held at Robinson College, Cambridge 6–9 August 1990 Bleehen, N.M.
1991
7 3 p. 171-178
8 p.
artikel
165 Research of a genetic predisposition to primary bronchopulmonary cancer by the study of debrisoquine hydroxylation phenotype 1991
7 3 p. 183-
1 p.
artikel
166 Research on smoking and lung cancer: A landmark in the history of chronic disease epidemiology 1991
7 3 p. 180-
1 p.
artikel
167 Restriction fragment length polymorphism analysis of the L-myc gene locus in a case-control study of lung cancer 1991
7 3 p. 188-189
2 p.
artikel
168 Restriction fragment length polymorphism of chromosome 3 (3p) and the epidermal growth factor receptor gene in human non-small cell lung carcinomas 1991
7 3 p. 184-185
2 p.
artikel
169 Results of pulmonary angioplastic operations for cases of bronchogenic carcinoma 1991
7 3 p. 199-
1 p.
artikel
170 Results of surgical treatment for primary lung cancer in Yamagata Prefecture 1991
7 3 p. 197-
1 p.
artikel
171 Retinoic acid and epidermal growth factor binding in retinoid-mediated invasion suppressed human lung carcinoma cells 1991
7 3 p. 187-
1 p.
artikel
172 Sclerosing epitheloid angiosarcoma of bone and lung-intravascular sclerosing bronchioloalveolar tumor 1991
7 3 p. 190-191
2 p.
artikel
173 Screening for lung cancer. Is it worthwhile? 1991
7 3 p. 179-
1 p.
artikel
174 Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen 1991
7 3 p. 189-
1 p.
artikel
175 Sex-associated differences in presentation and survival in patients with lung cancer 1991
7 3 p. 195-
1 p.
artikel
176 Short- and long-term synergistic effects of human tumor necrosis factor and interferon-gamma on A549 human lung cancer cells maintained in three-dimensional culture 1991
7 3 p. 187-188
2 p.
artikel
177 Shunt between right subclavian vein and the left heart in superior vena cava obstruction due to lung cancer 1991
7 3 p. 195-
1 p.
artikel
178 Sleeve lobectomy for double primary lung cancer; adenocarcinoma and early stage squamous cell carcinoma in one lobe 1991
7 3 p. 198-
1 p.
artikel
179 Small cell bronchogenic carcinoma: A cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposide 1991
7 3 p. 208-
1 p.
artikel
180 Small-cell lung carcinoma. Usefulness of initial staging for therapeutic decisions 1991
7 3 p. 191-
1 p.
artikel
181 Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients 1991
7 3 p. 186-
1 p.
artikel
182 Studies on lung cancer patients with microscopic residual tumor at the resected margin 1991
7 3 p. 197-
1 p.
artikel
183 Superior antiproliferative effects mediated by interferon-α entrapped in liposomes against a newly established human lung cancer cell line 1991
7 3 p. 188-
1 p.
artikel
184 Surgical adjuvant therapy, especially neoadjuvant therapy of lung cancer 1991
7 3 p. 210-
1 p.
artikel
185 Surgical treatment of small cell lung cancer 1991
7 3 p. 199-
1 p.
artikel
186 Teniposide (VM26) as second-line treatment for small cell lung cancer 1991
7 3 p. 202-
1 p.
artikel
187 The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging 1991
7 3 p. 193-
1 p.
artikel
188 The changing pattern of lung cancer by histological type — a review of 1151 cases from a university hospital in Japan, 1970–1989 Ikeda, Togo
1991
7 3 p. 157-164
8 p.
artikel
189 The clinical effect of medroxyprogesterone (MPA) in elderly patients with lung cancer 1991
7 3 p. 201-
1 p.
artikel
190 The diagnostic value of neuron-specific anolase and carcino-embryonic antigen analyses in patients with carcinoma of the lung 1991
7 3 p. 192-
1 p.
artikel
191 The formation of 3-methylcholanthrene-initiated lung tumors correlates with induction of cytochrome P450IA1 by the carcinogen in fetal but not adult mice 1991
7 3 p. 181-
1 p.
artikel
192 The positive bronchus sign in patients with known lung cancer 1991
7 3 p. 191-
1 p.
artikel
193 The use of biomarkers in the prediction of survival in patients with pulmonary carcinoma 1991
7 3 p. 192-
1 p.
artikel
194 The use of clonogenic assays in assessing the response of human lung cancer cell lines to α and gamma interferons alone or in combination with adriamycin 1991
7 3 p. 207-
1 p.
artikel
195 Three cases of pneumothorax due to lung cancer 1991
7 3 p. 195-
1 p.
artikel
196 Time trends in the outcome of lung cancer management: A study of 9,090 cases diagnosed in the Mersey Region, 1974–1986 1991
7 3 p. 209-
1 p.
artikel
197 Total and cause-specific mortality in cohorts of asbestos-cement workers and referents between 1907 and 1985 1991
7 3 p. 179-
1 p.
artikel
198 Tracheal mucus rheology in patients undergoing diagnostic bronchoscopy. Interrelations with smoking and cancer 1991
7 3 p. 193-
1 p.
artikel
199 Treatment of lung cancer: Therapeutic possibilities and new progress in molecular biology 1991
7 3 p. 211-
1 p.
artikel
200 Tumor lysis syndrome after induction chemotherapy in small-cell lung carcinoma 1991
7 3 p. 190-
1 p.
artikel
201 Urokinase receptors in lung cancer and normal lung 1991
7 3 p. 185-
1 p.
artikel
202 Usefulness of computed tomography guided percutaneous fine needle aspiration lung biopsy 1991
7 3 p. 195-
1 p.
artikel
203 Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma 1991
7 3 p. 193-
1 p.
artikel
204 v-ras(H) Induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line 1991
7 3 p. 186-
1 p.
artikel
                             204 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland